News & Articles

Learn how COVID-19 serology testing may inform long-term vaccination strategy and influence short-term prioritization and delivery

Infectious disease expert shares how robust LC columns are facilitating the analysis of complex pathogen samples

Dr. Frank Peacock discusses the impact of delayed care in the ED setting, the power of high-sensitivity troponin assays, and the value of point of care

Labs processing 2,000 to 5,000 tests a day can finally enjoy the benefits of Total Laboratory Automation (TLA) with a compact workflow-automation solution that fits needs

KSQ Therapeutics uses technology created at MIT to study the role of every human gene in disease biology

Vaccine, trialed in 450 children, shows favorable safety profile and was well-tolerated

COVID-19 infections fell by 65% percent after a first dose of the Oxford-AstraZeneca or Pfizer-BioNTech vaccines in this large community surveillance study

A new Prenetics Innovation Technology Centre will be established for advanced molecular diagnostics

Sensor could be used in discovering new treatments for mental illness, in neuroscience research and to detect drugs of abuse

Anti-cancer drug delivery to target tumor sites now becomes more effective with novel multi-stimuli-responsive drug delivery systems

The MDC Lighthouse Lab in Cheshire, which plays a key role in the UK Government’s COVID-19 testing rollout, has announced it has processed its 10 millionth test

Dr. Tania Nolan outlines how her team is designing assays to identify new variants and why these are critical to managing the global response

Each line of ValuPanel Reagents consists of separately delivered probes and primers, which allow assay flexibility and sizes that can help facilitate scale-up

AI could hold the key to more targeted treatment, according to new research

Watch world-leading scientists online, May 11-12, to discover the latest tools and techniques advancing COVID-19 research, immunotherapy development, drug screening, cancer diagnostics and more

The BinaxNOW Self-Test will be sold in 2-count packs for an MSRP of $23.99, making it an affordable over-the-counter COVID-19 rapid test available in the U.S.